MétaCan
Menu
Back to cohort
Record W4411365741 · doi:10.1177/09612033251352709

Immunosuppressive therapy withdrawal in lupus nephritis, is it possible?: A systematic review

2025· review· en· W4411365741 on OpenAlexaboutno aff
Stefanus Gunawan Kandinata, Awalia Awalia, Yuliasih Yuliasih, Lita Diah Rahmawati, Cahyo Wibisono Nugroho, Arinditia Triasti Putri, Angela Kimberly Tjahjadi, Mega Kahdina, Mandana Nikpour

Bibliographic record

VenueLupus · 2025
Typereview
Languageen
FieldMedicine
TopicSystemic Lupus Erythematosus Research
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineLupus nephritisDiscontinuationInternal medicineObservational studyProteinuriaRandomized controlled trialSystemic lupus erythematosusKidneyDisease

Abstract

fetched live from OpenAlex

IntroductionMaintenance of immunosuppressants (IST) is critical for sustaining remission in lupus nephritis (LN) patients. However, long-term use is associated with an increased risk of side effects such as infection. Yet, early IST withdrawal also poses a high risk of flare. This study aims to provide an overview of the impact of optimal IST withdrawal in patients with LN who have achieved remission.MethodWe conducted a systematic review of randomized controlled trials (RCTs) and observational studies regarding the discontinuation of IST in patients with proliferative LN who had been in remission for at least 1 year. Data from PubMed, ProQuest, and Web of Science were extracted on patient demographics, baseline characteristics, treatment regimens, and outcomes, including flare rates, renal function, and biopsy findings. The risk of bias was assessed using the Newcastle-Ottawa Scale and the JADAD Score.ResultsFive studies with 310 patients were included. The mean age of participants ranged from 26 to 38 years. Overall, flares following IST withdrawal occurred in an average of 28.7% of patients. Between the two groups (flare and no-flare), baseline serum creatinine was comparable, but baseline proteinuria and C3 & C4 levels were varied across studies. The duration of lupus before study entry was approximately 4-10 years, with a duration of complete remission of 12-59.5 months before IST withdrawal. Follow-up periods ranged from 24 to 215 months. The Biopsy Activity Index and Chronicity Index at baseline also showed variation but generally indicated a higher level of chronic damage in the flare group.DiscussionDiscontinuation of IST is feasible but may be associated with an increased risk of severe flares, often requiring reintroduction of induction therapy. Careful assessment and monitoring of both histologic and clinical activity are essential when evaluating remission and considering IST withdrawal, as a low activity index may guide safer withdrawal strategies.ConclusionIST withdrawal is feasible in patients with LN who have achieved remission, but careful monitoring is required due to the risk of relapse and potential progression of chronic kidney damage. Histological confirmation and predictive tools may support safer withdrawal decisions.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.012
metaresearch head score (Gemma)0.041
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.012
Threshold uncertainty score0.062

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0120.041
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0110.008
Bibliometrics0.0120.011
Science and technology studies0.0010.001
Scholarly communication0.0030.003
Open science0.0020.002
Research integrity0.0020.001
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.038
GPT teacher head0.371
Teacher spread0.333 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueLupusSame topicSystemic Lupus Erythematosus ResearchFrench-language works237,207